Kenvue KVUE announced that it has agreed to be acquired by Kimberly-Clark KMB at an enterprise value of roughly $48.7 billion ...
A Starbucks coffee shop in Beijing in April. The U.S. company is selling a stake in its China business to a Chinese private-equity firm. Starbucks Corp. is selling a majority stake in its China ...
Hims & Hers said that the discussions with Novo Nordisk (DK:NOVO.B) are ongoing, that "no definitive agreement" has been reached, and that the two companies may not reach one. Nonetheless, Hims & Hers ...
Alphabet said last week its Google Search business has remained strong. On a post-earnings call, Chief Executive Sundar Pichai said that overall queries and commercial queries have continued to ...
2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...
The company raised its full-year guidance as a result of its momentum. Palantir now anticipates around $4.40 billion in revenues for the 2025 fiscal year, up from the $4.14 billion to $4.15 billion ...
ServiceNow (NOW) integrates AI governance into enterprise platforms. As AI proliferates, companies need systems to track which models are deployed where, monitor their decisions and ensure compliance.
IPC Indice de Precios Y Cotizaciones Ends 0.98% Lower at 62153.30 — Data Talk — Update The IPC Indice de Precios Y Cotizaciones is down 615.88 points or 0.98% today to 62153.30 ...
Dow Jones Top Company Headlines at 7 PM ET: Palantir Revenue Climbs to Another Record as Defense Work Booms | Denny's ... The company said its sales were $1.18 billion in the third quarter for a ...
Dow Jones Top Markets Headlines at 7 PM ET: S&P, Nasdaq Rise to Kick Off November | Embattled ... The S&P 500 and Nasdaq rose, fueled by investor optimism over companies' continued spending spree on ...
Shares of Sarepta Therapeutics Inc. plunged in extended trading Monday after the biotechnology company disclosed disappointing drug-trial data, which could lengthen the timeline of the regulatory ...
Novonix struck a deal in 2024 to supply Stellantis with as much as 115,000 metric tons of synthetic graphite over six years from the start of 2026. It has also signed supply agreements with Panasonic ...